Editorial: Hormone refractory metastatic prostate cancer
- 1 May 1992
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 3 (5) , 331-335
- https://doi.org/10.1093/oxfordjournals.annonc.a058201
Abstract
Cora N. Stemberg, MD., FACP; Editorial: Hormone refractory metastatic prostate cancer, Annals of Oncology, Volume 3, Issue 5, 1 May 1992, Pages 331–335, https:This publication has 31 references indexed in Scilit:
- Original article: Prognostic factors in hormone-resistant progressing cancer of the prostateAnnals of Oncology, 1992
- A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostateCancer, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Comparison of flutamide and emcyt in hormone-refractory metastatic prostatic cancerUrology, 1988
- Benefits of Combination Therapy with Flutamide in Patients Relapsing after CastrationBritish Journal of Urology, 1988
- Effects of High-Dose Ketoconazole in Patients with Androgen-Independent Prostatic CancerAmerican Journal of Clinical Oncology, 1988
- Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.Journal of Clinical Oncology, 1985
- Carcinoma of the prostate: Relationship of pretreatment hormone levels to survivalEuropean Journal of Cancer and Clinical Oncology, 1984
- Advanced prostatic carcinoma Flutamide therapy after conventional endocrine treatmentUrology, 1975
- Orchiectomy for advanced prostatic carcinoma A reevaluationUrology, 1973